Orthobiologic procedures, such as platelet-rich plasma (PRP) injections and stem cell therapy, have emerged as promising treatments for a variety of musculoskeletal conditions in neonates. These procedures offer the potential to promote tissue healing, reduce inflammation, and improve joint function without the need for invasive surgery. However, pain management during ortho-biologic procedures in neonates can be challenging due to their immature nervous system and limited ability to communicate their pain.
Regional anesthesia techniques offer a safe and effective alternative to general anesthesia for ortho-biologic procedures in neonates. By providing localized analgesia, regional anesthesia can minimize the need for systemic opioids, which can have significant side effects in infants. Additionally, regional anesthesia can reduce the risk of postoperative complications, such as respiratory depression and hypotension.
Several types of regional anesthesia techniques can be used for orthobiologic procedures in neonates. The most common techniques include:
Caudal block: This technique involves injecting a local anesthetic solution into the caudal space, which is located at the base of the spine. Caudal blocks are effective for procedures involving the lower extremities, such as PRP injections into the hip or knee joints.
Epidural block: This technique involves injecting a local anesthetic solution into the epidural space, which is located around the spinal cord. Epidural blocks can provide analgesia for procedures involving the trunk and lower extremities.
Peripheral nerve blocks: These techniques involve injecting a local anesthetic solution near specific peripheral nerves to block sensation in a particular area of the body. Several different peripheral nerve blocks can be used for orthobiologic procedures in neonates, depending on the specific procedure being performed.
Regional anesthesia offers several benefits for ortho-biologic procedures in neonates, including:
Reduced need for systemic opioids: Opioids can have significant side effects in infants, such as respiratory depression, hypotension, and sedation. Regional anesthesia can minimize the need for opioids, reducing the risk of these side effects.
Improved postoperative pain management: Regional anesthesia can provide effective pain relief for several hours after the procedure, reducing the need for additional pain medication.
Decreased risk of postoperative complications: Regional anesthesia can reduce the risk of postoperative complications, such as respiratory depression and hypotension.
Faster recovery time: Neonates who receive regional anesthesia for ortho-biologic procedures typically have a shorter recovery time and can return to their normal activities sooner.
Although regional anesthesia is a safe and effective technique for ortho-biologic procedures in neonates, there are several factors to consider when using these techniques, including:
The infant's age and weight: The appropriate dosage of local anesthetic will depend on the infant's age and weight.
The type of ortho-biologic procedure: The specific type of regional anesthesia technique used will depend on the location of the procedure.
The infant's overall health: Infants with certain medical conditions may not be candidates for regional anesthesia.
The availability of experienced providers: Regional anesthesia techniques should only be performed by experienced providers who are trained in neonatal anesthesia.
Regional anesthesia is a valuable tool for pain management during ortho-biologic procedures in neonates. By providing effective analgesia and minimizing the need for systemic opioids, regional anesthesia can help to improve the safety and efficacy of these procedures.
1.
New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
Which Salvage Therapy Is Best for Recurrent Prostate Cancer?
4.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
5.
A radiotheranostic approach designed to combat aggressive cancers
1.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
2.
Exploring the Latest Advances in PTLD Cancer Treatment
3.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
4.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
5.
Polyposis Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
5.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation